Precursors and pathogenesis of ovarian carcinoma
References (186)
- et al.
Current concepts in epithelial ovarian tumors: does benign to malignant transformation occur?
Hum Pathol
(1992) - et al.
Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcino-ma
Gynecol Oncol
(1992) The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?
Gynecol Oncol
(1999)- et al.
Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis
Am J Pathol
(2004) - et al.
A critical re-appraisal of BRCA1 methylation studies in ovarian cancer
Gynecol Oncol
(2010) - et al.
Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause
Am J Obstet Gynecol
(2004) - et al.
Diverse tumorigenic pathways in ovarian serous carcinoma
Am J Pathol
(2002) - et al.
K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary
Gynecol Oncol
(2001) - et al.
KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants
Gynecol Oncol
(2006) - et al.
Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas
Hum Pathol
(2002)
Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary
Gynecol Oncol
(2010)
The cell of origin of ovarian epithelial tumours
Lancet Oncol
(2008)
Primary paraovarian cystadeno-carcinoma: clinical and management aspects and literature review
Gynecol Oncol
(1990)
Tubal origin of ‘ovarian’ low-grade serous carcinoma
Mod Pathol
(2011)
Prevalence of endometriosis in malignant epithelial ovary tumours
Eur J Obstet Gynecol Reprod Biol
(2003)
The pathological assessment of ovarian neoplasms. I: Introduction to the common ‘epithelial’ tumours and analysis of benign ‘epithelial’ tumours
Pathology
(1979)
Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach
Gynecol Oncol
(2003)
Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers
Gynecol Oncol
(2006)
Specific keynote: hereditary ovarian cancer: what we know
Gynecol Oncol
(2003)
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
Am J Hum Genet
(2001)
Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase
Mod Pathol
(2010)
Ovarian cancer and hormone replacement therapy in the Million Women Study
Lancet
(2007)
Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma
Gynecol Oncol
(2008)
Recent advances in the understanding of the pathogenesis of serous carcinoma: the concept of low-and high-grade disease and the role of the fallopian tube
Diagn Histopathol
(2008)
Risk factors for a serous cancer precursor (‘p53 signature’) in women with inherited BRCA mutations
Gynecol Oncol
(2008)
Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers
Mod Pathol
(2009)
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
Gynecol Oncol
(2008)
Histologic transformation of benign endometriosis to early epithelial ovarian cancer
Gynecol Oncol
(1996)
Prevalence of ovarian endometriosis in epithelial ovarian cancer
Int J Gynaecol Obstet
(1997)
Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study
Gynecol Oncol
(2000)
Familial risk among Japanese patients with endometriosis
Int J Gynaecol Obstet
(2004)
Global cancer statistics
CA Cancer J Clin
(2011)
Early de novo ovarian carcinoma. A study of fourteen cases
Cancer
(1994)
Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications
Int J Gynecol Pathol
(2008)
Ovarian cancer
Ann Rev Pathol
(2009)
Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases
Virchows Archiv
(2010)
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
J Pathol
(2001)
Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Am J Surg Pathol
(2010)
Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data
Int J Gynecol Pathol
(2004)
Grading ovarian serous carcinoma using a two-tier system
Am J Surg Pathol
(2004)
In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours
J Pathol
(2004)
Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor)
Int J Gynecol Pathol
(2003)
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation
Am J Surg Pathol
(2005)
Histologic subtypes of ovarian carcinoma: an overview
Int J Gynecol Pathol
(2008)
Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems
Adv Anat Pathol
(2009)
Fallopian tube precursors of ovarian low- and high-grade serous neoplasms
Histopathology
(2013)
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory
Am J Surg Pathol
(2010)
The pathology of and controversial aspects of ovarian borderline tumours
Curr Opin Oncol
(2010)
Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases
Am J Surg Pathol
(1996)
In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential
Virchows Archiv
(1999)
Cited by (115)
Clinical outcomes following identification of an incidental p53 signature in the fallopian tube
2024, Gynecologic Oncology ReportsMolecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment
2022, Seminars in Cancer BiologyCitation Excerpt :One major distinctive feature is the disease stage at diagnosis, with LGSC cases usually detected at an early stage (FIGO stage I-II), in contrast to HGSC. The origin of LGSC is presumably a stepwise malignant transformation process, with lesions evolving from serous borderline tumors [43,44]. The rate of serous borderline tumors progressing into LGSC is around 5–10% [14,42,44].
Insight updating of the molecular hallmarks in ovarian carcinoma
2020, European Journal of Cancer, Supplement
Copyright © 2013 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.